OraSure Technologies EBITDA 2010-2025 | OSUR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

OraSure Technologies ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

OraSure Technologies ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$220.2B
Boston Scientific (BSX)	$157B
Stryker (SYK)	$154B
EssilorLuxottica (ESLOY)	$136.6B
Medtronic (MDT)	$119.2B
Lonza Group Ag (LZAGY)	$50.3B
Haleon (HLN)	$44.4B
ResMed (RMD)	$40.3B
GE HealthCare Technologies (GEHC)	$35.5B
Agilent Technologies (A)	$34.1B
Terumo (TRUMY)	$25.8B
Koninklijke Philips (PHG)	$25.2B
Insulet (PODD)	$20.4B
Zimmer Biomet Holdings (ZBH)	$19.3B
Baxter (BAX)	$15B
Smith & Nephew SNATS (SNN)	$13.9B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$7.2B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.2B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.9B
AtriCure (ATRC)	$1.6B
Acuren (TIC)	$1.4B